LIAISON Murex HBsAg Qual; LIAISON XL; LIAISON diluteX— 510(k) K260770
Substantially EquivalentDiaSorin, Inc.
FDA 510(k) clearance K260770 for LIAISON Murex HBsAg Qual; LIAISON XL; LIAISON diluteX, Substantially Equivalent on 2026-06-04. Applicant: DiaSorin, Inc.. Device class: 2.
Clearance details
- Applicant
- DiaSorin, Inc.
- Product code
- Code LOM
- Device class
- Class 2
- Regulation
- 21 CFR 866.3172
- Advisory panel
- Microbiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Stillwater, MN, US
More clearances from DiaSorin, Inc.
view all- DEN250032 — LIAISON® XL MUREX Anti-HDV (318260); LIAISON® XL MUREX Control Anti-HDV (318261)
- K231214 — LIAISON VZV IgG HT, LIAISON Control VZV IgG HT
- K223403 — LIAISON Anti-HAV; LIAISON XS
- K213858 — LIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus
- K213936 — LIAISON MeMed BV, LIAISON MeMed BV Control Set
Adverse events under product code LOM
product code LOM- Malfunction
- 1,251
- Total
- 1,251
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Data sourced from openFDA. This site is unofficial and independent of the FDA.